This excerpt taken from the ELN 6-K filed Apr 11, 2005.
22 Disposals of Subsidiary Undertakings
Details of the disposal of subsidiary undertakings are given below:
In February 2004, we sold certain of our European subsidiary undertakings to Zeneus.
On 3 July 2003, we sold ElanTransdermal Technologies (ETT) to Nitto Americas. Other subsidiary undertakings sold includes Elan Drug Delivery Ltd, sold on 10 July 2003; Elan Pharma Taiwan sold on 24 March 2003 and Elan Pharmaceutical Corporation, Philippines sold in January 2003.
The gains or losses on the disposal of subsidiary undertakings are included in the gain on disposal of businesses line item. See Note 4 to the Consolidated Financial Statements for additional information.